BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
See today's BioWorld MedTech
Home
» Amulyte takes Crowd Funding route to get device to market
To read the full story,
subscribe
or
sign in
.
Amulyte takes Crowd Funding route to get device to market
Oct. 16, 2013
By
Omar Ford
So just what can a med-tech start-up do to secure funding in a time where venture capital investors are extremely conservative with investment dollars? Why go to Crowd Investing of course.
Medical technology